Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Jun 12 2019 | HFSA Releases 23rd Annual Scientific Meeting Advance Program Practice News Read More Jun 4 2019 | HFSA Sponsors Advanced Heart Failure and Transplant Cardiology (AHFTC) Fellowship Through ERAS® and NRMP® Match Practice News Read More May 30 2019 | Steps Outlined by ABIM and Cardiovascular Specialty Societies To Help Cardiologists Maintain Maintenance of Certification (MOC) Status Practice News Read More May 20 2019 | Deadlines Approaching for 23rd HFSA Annual Scientific Meeting Practice News Read More May 8 2019 | U.S. FDA Approves VYNDAQEL® and VYNDAMAX™ for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fatal Disease Practice News Read More Pagination First page « First Previous page ‹ Previous … Page 12 Page 13 Page 14 Page 15 Current page 16 Page 17 Page 18 Page 19 Page 20 … Next page Next › Last page Last »
Jun 4 2019 | HFSA Sponsors Advanced Heart Failure and Transplant Cardiology (AHFTC) Fellowship Through ERAS® and NRMP® Match Practice News Read More
May 30 2019 | Steps Outlined by ABIM and Cardiovascular Specialty Societies To Help Cardiologists Maintain Maintenance of Certification (MOC) Status Practice News Read More
May 8 2019 | U.S. FDA Approves VYNDAQEL® and VYNDAMAX™ for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fatal Disease Practice News Read More
